- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.04. | VITURA HEALTH LIMITED: Business Transformation Update | - | ASX | ||
| 21.04. | Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million | 1 | smallcaps.com.au | ||
| 20.04. | VITURA HEALTH LIMITED: Doctors on Demand Performance Update | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 07.04. | VITURA HEALTH LIMITED: Resignation of Non-Executive Director | - | ASX | ||
| 02.04. | VITURA HEALTH LIMITED: Appointment of Chief Executive Officer | - | ASX | ||
| 29.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 22.03. | VITURA HEALTH LIMITED: Cortexa advances commercialisation of MDMA supply | - | ASX | ||
| 17.03. | Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products | 2 | smallcaps.com.au | ||
| 16.03. | VITURA HEALTH LIMITED: VIT enters distribution agreement with MedReleaf Australia | - | ASX | ||
| 12.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Investor Presentation | 2 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Results Release | 1 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Results Investor Webinar | 3 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Appendix 4D and Half Year Report | 2 | ASX | ||
| 23.02. | VITURA HEALTH LIMITED: Revised Trading Policy | 3 | ASX | ||
| 03.02. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | 1 | ASX | ||
| 28.01. | VITURA HEALTH LIMITED: CEO Transition and Interim Leadership Update | - | ASX | ||
| 11.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 09.01. | VITURA HEALTH LIMITED: Appointment of Chief Financial Officer | 3 | ASX |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,882 | +0,56 % | AURORA CANNABIS INC: Ruhe vor dem nächsten Impuls | ||
| TILRAY BRANDS | 4,610 | -0,11 % | Tilray Brands Inc (2): Tilray Brands' Blue Point rolls out Magic Hour IPA | ||
| ORGANIGRAM GLOBAL | 0,982 | +3,37 % | Organigram Says Vape Weakness Pressures Margins | ||
| SNDL | 1,201 | +0,33 % | SNDL Inc.: SNDL Reports First Quarter 2026 Financial and Operational Results | EDMONTON, Alberta, April 29, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,890 | 0,00 % | XFRA 0NF1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen | |
| BIONANO GENOMICS | 1,255 | -0,40 % | Bionano Genomics: Bionano Announces Leadership Transition | SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano's Board of Directors, has been appointed interim president... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 11,260 | -0,62 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights | In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA, 3,588 patients initiated treatment, and ~5,400 prescriptions were filled Agreement signed in May with leading... ► Artikel lesen | |
| HIGH TIDE | 2,140 | +3,13 % | High Tide erzielt über Remexian Pharma GmbH einen vierteljährlichen Vertriebsrekord von 7,6 Tonnen medizinischem Cannabis und baut seine Führungsrolle im deutschen Markt weiter aus | CALGARY, AB, 6. Mai 2026 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA) - ein einflussreiches und auf
den Einzelhandel ausgerichtetes... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 5,000 | -2,91 % | Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma | SEATTLE and VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused... ► Artikel lesen | |
| JAGUAR HEALTH | 3,250 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule | SAN FRANCISCO, CA / ACCESS Newswire / May 8, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided an update on the status of the Company's listing on The Nasdaq Stock... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,004 | 0,00 % | XFRA C4T: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGREENRISE GLOBAL... ► Artikel lesen | |
| MEDIPHARM LABS | 0,049 | 0,00 % | MediPharm Labs Corp.: MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results | ||
| ARGENT BIOPHARMA | 0,013 | 0,00 % | ARGENT BIOPHARMA LIMITED: Final Director's Interest Notice - GH | ||
| AYR WELLNESS | 0,050 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell +3,23 % bei einem Aktienkurs von 0,016 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.